ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
往期阅览
版权信息

ISSN 3105-6741(Print)
ISSN 3105-675X(Online)
CODEN:LYYAA3
(国际标准连续出版物标识符·全球唯一标识符)
分配机构:美国化学文摘社(CAS)

编委会
主编

田明哲
同行评议专家

副主编
彭思妍  贺  颖  吕大传
曹  婷  文红琴  姜雨欣
曾浩宇  赖  萌  丁  妍
(以上排名不分先后顺序)
编委

编委会助理
施子辰
期刊主页
在线投稿
申请编委/副主编/同行评议专家
索引/检索/存档
DOI
EuroPub
欧洲学术出版中心数据库(英国)

Sci Online
研究者索引

欧亚科学期刊索引(ESJI)
武汉办事处
主任 库盛娟
电话 +86 027-8860 7188
邮箱 gjqk@qikan999.com
微信 qikan7188
地址 武汉市武昌东湖路181号
邮编 430077
Editing and Publishing
Macau Sino-Foreign Medical Publishing Limited(MSFMP)
Address
7th Floor,D, No.19,Palawak
Lane, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
http://lcyyyj.scionline2025.com

  首页 -> 往期阅览-> 2025年
《临床用药研究》( ISSN3105-6741、EISSN3105-675X ) 发布者:Quest Press 发布日期:2026/1/11
10.12479/questpress-lcyyyj.20250216 Open Access 下载0 浏览29

 

基于网络药理学及分子对接研究小儿荆杏止咳颗粒治疗急性支气管炎的作用机制

李世珍   和旭丽   申翠平
1.吕梁市人民医院,山西吕梁,033099 2.太原市妇幼保健院,山西太原,030012 3.长治市人民医院,山西长治,046000
摘要:目的:通过网络药理学和计算机分子对接技术研究小儿荆杏止咳颗粒治疗急性支气管炎的作用机制。方法:使用TCMSP平台及文献数据搜索建立小儿荆杏止咳颗粒物质基础数据库,以ADMET3.0和TCMSP等平台进行成药性评价筛选,利用PDB及Uniprot数据库对靶点蛋白基因名称标准化;利用Genecards数据库和OMIM数据库对急性支气管炎的相关靶点进行收集和筛选;通过Venny2.1.0软件获取小儿荆杏止咳颗粒治疗急性支气管炎的潜在靶点后导入STRING数据库构建蛋白相互作用网络;采用Cytoscape3.10.3软件构建药物-成分-靶点网络;接着用David和Metascape数据库进行GO/KEGG通路富集。最后通过Autodockvina软件将小儿荆杏止咳颗粒活性成分与急性支气管炎核心靶点进行分子对接研究。结果:获得小儿荆杏止咳颗粒靶点1004个,急性支气管炎靶点1150个,小儿荆杏止咳颗粒作用于急性支气管炎靶点177个,进一步发现核心靶点与炎症通路密切相关。结论:小儿荆杏止咳颗粒可能通过鼠尾草素、5,7,2',6'-四羟基黄酮、刺槐素、乌拉尔宁B、粘毛黄芩素Ⅱ等活性成分群多靶点多重作用机制共同作用,研究发现SRC、NFKB1、MTOR、CASP3和AKT1等为小儿荆杏止咳颗粒作用的核心靶点,通过调节白细胞介素信号传导通路、细胞迁移的正向调控、胃泌素信号传导、急性病毒性心肌炎等通路,起到抗炎、抗氧化作用,对急性支气管炎起到治疗作用,为小儿荆杏止咳颗粒临床治疗提供实验基础和理论依据。
关健词:小儿荆杏止咳颗粒;急性支气管炎;成药性评价;作用机制;网络药理学;分子对接
Study on the Mechanism of Action of Xiao'er Jingxing Zhike Granules in Treating Acute Bronchitis Based on Network Pharmacology and Molecular Docking
Shizhen Li1   Xuli He   Cuiping Shen
1.The People’s Hospital of Lvliang,Lvliang,Shanxi 033099,China 2.Taiyuan Maternity and Child Health Care Hospital,Taiyan,Shanxi 030012,China 3.Changzhi People's Hospital,Changzhi,Shanxi 046000,China
Abstract:Objective:To investigate the mechanism of action of Xiao'er Jingxing Zhike Granules in treating acute bronchitis using network pharmacology and molecular docking techniques.Methods:A material basis database for Xiao'er Jingxing Zhike Granules was established using the TCMSP platform and literature data. Drug-likeness evaluation and screening were conducted using platforms such as ADMET 3.0 and TCMSP. The target protein gene names were standardized using the PDB and Uniprot databases. Acute bronchitis-related targets were collected and screened using the Genecards and OMIM databases. Potential targets for Xiao'er Jingxing Zhike Granules in treating acute bronchitis were obtained using Venny 2.1.0 software and then imported into the STRING database to construct a protein-protein interaction (PPI) network. A drug-component-target network was constructed using Cytoscape 3.10.3 software. GO/KEGG pathway enrichment analysis was performed using the DAVID and Metascape databases. Finally,molecular docking studies were conducted using Autodock Vina software to investigate the interaction between the active components of Xiao'er Jingxing Zhike Granules and the core targets of acute bronchitis.Results:A total of 1004 targets for Xiao'er Jingxing Zhike Granules and 1150 targets for acute bronchitis were identified. Among these,177 targets were found to be common between Xiao'er Jingxing Zhike Granules and acute bronchitis. Further analysis revealed that the core targets are closely related to inflammatory pathways.Conclusion:Xiao'er Jingxing Zhike Granules may act on multiple targets and pathways through active components such as Salvigenin,5,7,2',6'-Tetrahydroxyflavone,Robinin,Uralenin B,and Viscidulin II. These components target core proteins such as SRC,NFKB1,MTOR,CASP3,and AKT1,regulating pathways including interleukin signaling,positive regulation of cell migration,gastrin signaling,and acute viral myocarditis. This multi-target,multi-pathway approach exerts anti-inflammatory and antioxidant effects,providing a therapeutic effect on acute bronchitis. This study provides an experimental and theoretical basis for the clinical use of Xiao'er Jingxing Zhike Granules in treating acute bronchitis.
Keywords : Xiao'er Jingxing Zhike Granules;Acute Bronchitis;Drug-likeness Evaluation;Mechanism of Action;Network Pharmacology;Molecular Docking

参考文献
[1] 刘志美,张瑜,马闻园,等.小儿抗炎胶囊治疗小儿急性支气管炎(风热咳嗽证)[J].吉林中医药,2023,43(10):1166-1169.DOI:10.13463/ j.cnki.jlzyy. 2023.10.012.
[2] 徐贤达,陈晓婷,杨芬.加味麻杏石甘汤治疗对小儿急性支气管炎患儿中医证候积分和炎症因子水平的影响[J].现代医学与健康研究电子杂志,2024,8(23):99-101.
[3] 史卜文,吕健,谢雁鸣,等.肺力咳合剂联合常规西药治疗小儿支气管炎的有效性和安全性系统评价与 Meta 分析[J].中国中医药信息杂志,2023,30(01):67-74.DOI:10.19879/j.cnki.1005-5304.202107545.
[4] 马莹,苏林博,吴辉,等.精细化护理管理在小儿急性支气管炎中的应用[J].河南医学高等专科学校学报,2024,36(05):651-653.
[5] 曹丽洁,欧阳侯静,付铄淇.中西医结合护理模式在小儿急性支气管炎中的应用价值[J].西部中医药,2023,36(08):123-126.
[6] 黄静,陈安静,鲁云倩,等.自拟“消咳贴”治疗小儿急性咳嗽风寒化热证的临床观察[J].中国中西医结合儿科学,2022,14(06):542-545.
[7] 魏向阳,张星平,张学青,等.痰热壅肺型小儿咳嗽变异性哮喘及小儿急性支气管炎异病同治刍议[J].中国药物经济学,2023,18(04):114-117+121.
[8] 刘咏梅,冯会颖,殷美乐,等.小儿荆杏止咳颗粒联合利巴韦林治疗小儿急性上呼吸道感染的临床研究[J].现代药物与临床,2024,39(09):2328-2332.
[9] 吴志坚,陈秋萍,刘素云.小儿荆杏止咳颗粒联合孟鲁司特钠治疗支气管肺炎患儿效果观察[J].天津药学,2023,35(04):40-43.
[10] 张琪,常久,季巍巍,等.网络药理学在中医药领域的研究进展[J].中国中医药信息杂志,2024,31(11):186-190.DOI:10.19879/j.cnki.1005-5304.202207685.
[11] 杨思佳,王晓燕,陈清清,等.急性支气管炎患儿不良预后发生率及多因素回归预测模型分析[J].中国妇幼保健,2024,39(19):3786-3789.DOI: 10. 19829/ j.zgfybj.issn.1001-4411.2024.19.026.
[12] 颉雅苹,曾强,陶建平,等.67 例儿童感染后闭塞性细支气管炎的临床特征与随访研究[J].临床肺科杂志,2023,28(05):689-693.
[13] 尹晓炜.小儿荆杏止咳颗粒辅助治疗小儿急性支气管炎的临床分析[J].适用中西医结合临床,2021,21(21):40-41.DOI:10.13638/j.issn.1671-4040.2021.21.018.
[14] NOORI S,HASSAN Z M,YAGHMAEI B,et al.Antitumor and immunomodulatory effects of salvigenin on tumor bearing mice[J].Cell Immunol,2013,286(1/2):16-21.
[15] Chan SC,Chang YS,Wang JP,Chen SC,Kuo SC. Three new flavonoids and antiallergic , anti-inflammatory constituents from the heartwood of Dalbergia odorifera. Planta Med. 1998 Mar ;64(2):153-8.doi:10.1055/s-2006-957394.PMID:9525107.
[16] 唐亚芳,杨岸新.中药川芎的有效成分及其药理作用 研 究 [J]. 中 国 现 代 药 物 应 用 , 2018 ,12(10):219-220.DOI:10.14164/j.cnki.cn11-5581/r.2018.10.125.
[17] 杨丽.当归、鸡血藤、丹参、红花补血与活血之探讨[J].中国中医急症,2010,19(09):1566-1567.
[18] Huang W C ,Liou C J .Dietary Acacetin Reduces Airway Hyperresponsiveness and Eosinophil Infiltration by Modulating Eotaxin-1 and Th2 Cytokines in a Mouse Model of Asthma[J]. Evidence-Based Complementray and Alternative Medicine,2012,(2012-9-24),2012,2012:910520. DOI:10.1155/2012/910520.
[19] Njamen D,Mbafor JT,Fomum ZT,Kamanyi A,Mbanya JC,Recio MC,Giner RM,Má?ez S,Ríos JL. Anti-inflammatory activities of two flavanones,sigmoidin A and sigmoidin B,from Erythrina sigmoidea. Planta Med. 2004 Feb ;70(2):104-7. doi:10.1055/s-2004-815484.PMID: 14994185.
[20] Biyiti L,Pesando D,Puiseux-Dao S,Girard JP,Payan P. Effect of antibacterial plant flavanones on the intracellular calcium compartment involved in the first cleavage of sea urchin eggs. Toxicon. 1990;28(3):275-83. doi:10.1016/0041-0101(90)90063-d. PMID: 2343463.
[21] Huang YX,Li NF,Li CY,Zheng FP,Yao XY,Lin BH,Huang XZ,Zhao NJ,Yang JY,Chen QM,Zhang MM,Yi LT,Chen XQ. Clinical features and effectiveness of Chinese medicine in patients with COVID-19 from overseas: A retrospective study in Xiamen,China. Front Public Health. 2022 Oct 24;10:1038017. doi: 10.3389/fpubh.2022.1038017. PMID: 36353282; PMCID: PMC9638095.
[22] Tsai PJ,Huang WC,Hsieh MC,Sung PJ,Kuo YH,Wu WH. Flavones Isolated from Scutellariae radix Suppress Propionibacterium Acnes-Induced Cytokine Production In Vitro and In Vivo. Molecules. 2015 Dec 24;21(1):E15. doi: 10.3390/molecules 21010015. PMID: 26712724 ; PMCID: PMC 6273464.
[23] Ren Q,Guo F,Tao S,Huang R,Ma L,Fu P. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Biomed Pharmacother. 2020 Feb;122:109772. doi: 10.1016/j.biopha.2019.109772. Epub 2019 Dec 30. PMID: 31918290.
[24] Sendler M,van den Brandt C,Glaubitz J,Wilden A,Golchert J,Weiss FU,Homuth G,De Freitas Chama LL,Mishra N,Mahajan UM,Bossaller L,V?lker U,Br?ker BM,Mayerle J,Lerch MM. NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-Inflammatory Response Syndromes in Mice With Acute Pancreatitis. Gastroenterology. 2020 Jan;158(1):253-269.e14.doi:10.1053/j.gastro.2019.09.040.Epub 2019 Oct 5.PMID:31593700.
[25] 潘静,张兵,党春晓,等.逍遥舒坤汤通过 PI3K/Akt/ mTOR 调控中性粒细胞胞外诱捕网治疗盆腔炎性疾病后遗症的机制[J/OL].中国实验方剂学杂志,1-14
[2024-12-13].https://doi.org/10.13422/j.cnki.syfjx. 20242236.
[26] 刘云,张小兵,张向明,等.丹皮酚对脓毒症小鼠心肌炎的保护作用及机制研究[J].中国临床研究,2024,37(11):1714-1718.DOI:10.13429/j.cnki. cjcr. 2024. 11.014.
[27] 李赋,张志明,张茂福,等.肺泡巨噬细胞自噬在急性肺损伤/急性呼吸窘迫综合征中的研究进展[J].中国急救医学,2024,44(11):1002-1006.
[28] 程蒙蒙,刘新光,魏焱鑫,等.通塞颗粒阻抑巨噬细胞炎症反应改善大鼠慢性阻塞性肺疾病急性加重[J].南方医科大学学报,2024,44(10):1995-2003.
[29] 范晓璇,颜培正,张庆祥.黄芪甲苷通过 LC3/Beclin 1 干预哮喘寒饮蕴肺证大鼠细胞自噬的机制[J].中华中医药杂志,2024,39(11):6037-6042.
[30] 易阳,周国平,钟闻燕,等.中性粒细胞、白介素-8 和弹性蛋白酶在急性毛细支气管炎发病中的作用[J].临床儿科杂志,2009,27(02):148-151.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.
 
  Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
About Quest Press / Macau Sino Int. Med. Press
关于 Quest Press 与 Macau Sino Int. Med. Press
  Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
  Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
  Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
  Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Call for Editorial Board Members/Associate Editors/Peer Reviewers/Editors-in-Chief
诚邀编委、副主编、同行评审专家及主编